As an intellectual property attorney in San Diego, California, I help innovative startup companies, universities, individual entrepreneurs, scientists, physicians, and investors bring early- and mid-stage technologies to market. In particular, I help clients of all sizes with developing comprehensive technology commercialization strategies which includes:
I founded Torrey Pines Law Group, PC in 2013 to continue my pursuit of helping innovators bring their technologies to market. The firm has grown to include fifteen of the nation's most accomplished patent attorneys, patent agents, FDA regulatory advisors, paralegals, scientists, engineers, and business counsel.
The firm is simply one of the best in the world operating at the intersection of Artificial Intelligence (AI), Biotechnology, Medical Device, Medical Diagnostics, and Pharmaceutical law. While the firm broadly handles IP, FDA regulatory and technology transactions for healthcare and life sciences innovators, I focus primarily on assisting the firm's clients with commercializing early-stage and mid-stage technologies created by startups, universities, and innovative international corporations.
I've been lucky to work with some of the smartest scientists, researchers, and entrepreneurs in the world. What I enjoy most about working closely with them is sharing the satisfaction of bringing their technologies to market -- whether it be a new therapeutic drug, a new healthcare service, new medical device, or things at the convergence of many disciplines that have never been imagined before. That feeling is just pure magic to me.
Perhaps the impulse to help entrepreneurs with bringing new technologies to market grew out of my desire to always push my own boundaries. I grew up a typical San Diego grom spending as much time in the ocean as I did sleeping. And because I have always loved the sciences, I attended my first introductory biology class at the Scripps Institution of Oceanography when I was 13. That subject spoke to me in a way that nothing else had. When I wasn't in the ocean, rock climbing in Joshua Tree, hiking the High Sierra, and traveling throughout the Southwest and Mexico, you could find me in the lab at UC San Diego researching the intersection of immunology and cancer.
I was fortunate to be raised just down the road from The Bishop's School and UCSD. At UCSD, I was an undergraduate Research Scholar and received a B.S. in Biochemistry/Chemistry with a minor degree in Economics. While conducting research in the laboratory of Dr. Dennis Carson, then head of the UC San Diego Moores Cancer Center, I investigated the role of novel purine nucleoside analogs in autoimmune diseases and cytokine mediated cell responses including apoptosis, rheumatoid arthritis, AIDS, and cancers. I then pursued my interests in the biotech industry where I investigated ribonucleic acid (RNA)-based therapeutics for treating viral infections.
Throughout my scientific and legal career, I've worked with a number of life sciences and healthcare innovations, but to provide a "short" list I have assisted innovators with: small molecule pharmaceuticals, biopharmaceuticals, biological drugs and therapeutics, monoclonal antibodies, bi-specific antibodies and antibody fragments, implantable medical devices, software as a medical device (SaMD), convergence technologies including artificial intelligence (AI), machine learning, deep learning, and complex algorithms, in vitro diagnostics (IVD), clinical diagnostics, companion diagnostics, systems related to personalized medicine, pharmacogenomics, stem cells including induced pluripotent stem cells (iPS cells), therapeutic cloning, RNA interference (RNAi), vaccines, ribozymes, antisense polynucleotides, enzymes, catalysts, non-naturally occurring polynucleotides and polypeptides, detection and screening assays, bioinformatics, structural proteomics, three-dimensional molecular modeling and drug design, transgenic plants, transgenic animals, and microorganism cell culture.
Since becoming a lawyer, I have assisted clients with private investments totaling over $100 million, and have assisted with the closing of business transactions totaling more than $1 billion. Before returning to San Diego, I worked in a prominent international law firm headquartered in Washington, DC (now called Dentons), and was the chief legal officer at a large university research foundation. I have also been chief in-house IP counsel with two medical device startups and an international biopharmaceutical company.